References

Arenz S, Wilson DN Bacterial Protein Synthesis as a Target for Antibiotic Inhibition. Cold Spring Harb Perspect Med. 2016; 6:(9) https://doi.org/10.1101/cshperspect.a025361

Becerra SC, Roy DC, Sanchez CJ, Christy RJ, Burmeister DM An optimized staining technique for the detection of Gram positive and Gram negative bacteria within tissue. BMC Res Notes. 2016; 9 https://doi.org/10.1186/s13104-016-1902-0

Daley MF, Arnold Rehring SM, Glenn KA, Reifier LM, Steiner JF Improving Antibiotic Prescribing for Pediatric Urinary Tract Infections in Outpatient Settings. Pediatrics. 2020; 145:(4) https://doi.org/10.1542/peds.2019-2503

Davies K, Bradley S, Crawford D Biological basis of child health 15: understanding the renal system and common renal conditions in children. Nurs Child Young People. 2022; 34:(4)33-42 https://doi.org/10.7748/ncyp.2022.e1392

Diamant M, Obolski U The straight and narrow: A game theory model of broad-and narrow-spectrum empiric antibiotic therapy. Math Biosci. 2024; 372 https://doi.org/10.1016/j.mbs.2024.109203

Hay AD, Costelloe C Antibiotics for childhood urinary tract infection: can we be smarter?. Br J Gen Pract. 2013; 63:(609)175-6 https://doi.org/10.3399/bjgp13X665099

Kohanski MA, Dwyer DJ, Collins JJ How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol. 2010; 8:(6)423-35 https://doi.org/10.1038/nrmicro2333

National Institute for Health and Care Excellence. Urinary tract infection (lower): antimicrobial prescribing. 2018a. https://www.nice.org.uk/guidance/ng109 (accessed 27 March 2025)

National Institute for Health and Care Excellence. Pyelonephritis (acute): Antimicrobial prescribing. 2018b. https://www.nice.org.uk/guidance/ng111 (accessed 27 March 2025)

Royal College of GPs. Summary of antimicrobial prescribing guidance - managing common infections. 2024. https://elearning.rcgp.org.uk/mod/book/view.php?id=14887 (accessed 27 March 2025)

Tullus K, Shaikh N Urinary tract infections in children. Lancet. 2020; 395:(10237)1659-1668 https://doi.org/10.1016/S0140-6736(20)30676-0

Vazouras K, Velali K, Tassiou I, Anastasiou-Katsiardani A, Athanasopoulou K, Barbouni A, Jackson C, Folgori L, Zaoutis T, Basmaci R, Hsia Y Antibiotic treatment and antimicrobial resistance in children with urinary tract infections. J Glob Antimicrob Resist. 2020; 20:4-10 https://doi.org/10.1016/j.jgar.2019.06.016

Wijma RA, Huttner A, Koch BCP, Mouton JW, Muller AE Review of the pharmacokinetic properties of nitrofurantoin and nitroxoline. J Antimicrob Chemother. 2018; 73:(11)2916-2926 https://doi.org/10.1093/jac/dky255

Yates A Urinalysis: how to interpret results. Nursing Times. 2016; 112:(2)1-3

A–Z of prescribing for children

02 April 2025
Volume 7 · Issue 4

Abstract

This series focuses on aspects of prescribing for neonates, children and young people, from A–Z. Aspects of pharmacokinetics will be considered, alongside legal considerations, consent and medications in schools

Urinary tract infections (UTIs) are one of the most common bacterial infections seen in childhood. An understanding of the three categories of UTIs are useful for knowing the correct treatment and management (Tullus and Shaikh, 2020) (Table 1), and identifying the area affected also has an impact on treatment.

Bacteria is found in all UTI cases, with Escherichia coli (E. coli) detected in up to 90% of cases, originating from faecal flora, with vaginal flora also affected in girls. E.coli is a gram-negative bacillus, which is in the normal intestinal flora, causing intestinal and extra-intestinal disturbances.

Gram-negative bacteria show up as pink or red after gram testing. Gram testing (or staining) is used to differentiate between types of bacteria by looking at cell wall properties; gram-negative bacteria have thinner cell walls, typical of E. coli (Becerra et al, 2016).

Knowledge of the different antibiotics that are available is imperative, including those factoring in the type of UTI the patient presents with. Appropriate treatment is essential, but is challenging due to the increasing resistance to commonly prescribed antibiotics (e.g. amino-penicillins), and the increasing trend of multi-drug-resistant organisms that cause UTIs (Vazouras et al, 2020). Broad spectrum antibiotics increase the chances of covering and treat the causing pathogen, which results in the patient's recovery; yet, this does increase the overall expansion of antibiotic resistance (Diamant and Obolski, 2024). This has been demonstrated, for example, in Greece, where resistance to ampicillin and trimethoprim/sulfamethoxazole has been cited as high as 51% and 29%, respectively (Vazouras et al, 2020). Therefore, antibiotic therapy should ideally be prescribed with a more narrow spectrum antibiotic, which can be based on local sensitivity patterns (Daley et al, 2020) and local antibiotic resistance data from Public Health England (NICE, 2018a).

Register now to continue reading

Thank you for visiting Journal of Prescribing Practice and reading some of our peer-reviewed resources for prescribing professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • New content and clinical newsletter updates each month